Altropane
Source: Wikipedia, the free encyclopedia.
Stimulant drug
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
JSmol) | |
| |
| |
| (verify) | |
Altropane (O-587, IACFT, 2β-carbomethoxy-3β-(4-fluorophenyl)-N-((E)-3-iodo-prop-2-enyl)tropane) is a
radiolabelled form for mapping the distribution of dopamine transporters in the brain,[1] and consequently this has led to its development as a potential diagnostic tool for early detection of Parkinson's disease.[2] It is also being investigated for potential use in the diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).[3][4]
References
| 2-Carboxymethyl Esters | |
|---|---|
| (3,4-Disubstituted Phenyl)-tropanes | |
| Arylcarboxy | |
| Carboxyalkyl | |
| Acyl | |
| β,α Stereochemistry | |
| α,β Stereochemistry | |
| Heterocycles: 3-Substituted-isoxazol-5-yl | |
| Heterocycles: 3-Substituted-1,2,4-oxadiazole | |
| N-alkyl |
|
| N-replaced (S,O,C) | |
| Irreversible |
|
| Nortropanes (N-demethylated) | |
 | This article related to medical imaging is a stub. You can help Wikipedia by expanding it. |